National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41123458.
- Also identified by DOI 10.1002/cncr.35946 and PMC identifier 12542882.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As cancer treatments evolve, there is a growing need to assess, analyze, and integrate measurements of cancer treatment tolerability. This report describes the rationale, development, and outcomes of the National Cancer Institute Cancer Treatment Tolerability Consortium, and discusses future opportunities for cancer treatment tolerability research.